We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+34.98%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$376M
AUM Growth
-$31.2M
Cap. Flow
-$73.1M
Cap. Flow %
-19.42%
Top 10 Hldgs %
14.32%
Holding
275
New
96
Increased
11
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
BLU
BELLUS Health Inc.
BLU
+$6.2M
2
PI icon
Impinj
PI
+$5.08M
3
HLIT icon
Harmonic Inc
HLIT
+$4.59M
4
EXTR icon
Extreme Networks
EXTR
+$3.71M
5
PLMR icon
Palomar
PLMR
+$3.42M

Sector Composition

Rank Sector Weight
1 Healthcare 33.5%
2 Technology 16%
3 Industrials 11.73%
4 Energy 11.68%
5 Consumer Staples 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRTC icon
151
iRhythm Holdings
IRTC
$4.11B
$1.37M 0.37%
10,969
-4,046
-27% -$584K
OTTR icon
152
Otter Tail
OTTR
$3.88B
$1.36M 0.36%
+22,174
New +$1.6M
EPM icon
153
Evolution Petroleum
EPM
$133M
$1.36M 0.36%
+195,381
New +$1.29M
NAT icon
154
Nordic American Tanker
NAT
$1.36B
$1.35M 0.36%
+504,921
New +$1.34M
ABOS icon
155
Acumen Pharmaceuticals
ABOS
$173M
$1.34M 0.36%
+133,161
New +$764K
FLNC icon
156
Fluence Energy
FLNC
$2.35B
$1.33M 0.35%
+90,998
New +$1.37M
PRCT icon
157
Procept Biorobotics
PRCT
$1.23B
$1.33M 0.35%
31,980
-11,133
-26% -$444K
LEU icon
158
Centrus Energy
LEU
$3.83B
$1.26M 0.34%
+30,818
New +$1.19M
TTMI icon
159
TTM Technologies
TTMI
$14.1B
$1.24M 0.33%
+93,975
New +$1.35M
TCDA
160
DELISTED
Tricida, Inc. Common Stock
TCDA
$1.22M 0.32%
116,056
-26,236
-18% -$287K
RGP icon
161
Resources Connection
RGP
$148M
$1.2M 0.32%
66,265
-17,225
-21% -$345K
VERV
162
DELISTED
Verve Therapeutics
VERV
$1.2M 0.32%
+34,785
New +$1.11M
FOLD
163
DELISTED
Amicus Therapeutics
FOLD
$1.16M 0.31%
110,623
-20,618
-16% -$230K
XAIR icon
164
Beyond Air
XAIR
$3.79M
$1.12M 0.3%
+375
New +$1.41M
ACLS icon
165
Axcelis
ACLS
$4.12B
$1.11M 0.3%
18,370
-30,099
-62% -$1.94M
CTIC
166
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$1.1M 0.29%
189,303
-222,803
-54% -$1.39M
ALT icon
167
Altimmune
ALT
$583M
$1.08M 0.29%
84,821
-41,174
-33% -$608K
CUTR
168
DELISTED
Cutera, Inc.
CUTR
$1.07M 0.29%
23,567
-38,292
-62% -$1.75M
AXTI icon
169
AXT Inc
AXTI
$5.01B
$1.05M 0.28%
+157,019
New +$1.23M
HDSN
170
Hudson Technologies
HDSN
$242M
$978K 0.26%
133,047
-153,731
-54% -$1.29M
HROW icon
171
Harrow
HROW
$1.49B
$802K 0.21%
+66,420
New +$539K
FPI
172
Farmland Partners
FPI
$419M
$634K 0.17%
50,045
-100,814
-67% -$1.44M
AIR icon
173
AAR Corp
AIR
$5.81B
-89,881
Closed -$3.76M
AIZ icon
174
Assurant
AIZ
$14.2B
-13,230
Closed -$2.29M
AMPH icon
175
Amphastar Pharmaceuticals
AMPH
$882M
-48,505
Closed -$1.69M

Similar funds

EAM Global Investors's Q3 2022 Portfolio in Review

As of Q3 2022, EAM Global Investors held 275 positions worth $376M, down 7.7% from $407M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

EAM Global Investors withdrew a net $73.1M in Q3 2022, closing 103 positions and reducing 42 holdings. Its most notable exit was FLEX LNG, an estimated $7.59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Global Investors opened a new position in BELLUS Health Inc. worth $6.19M.

  • EAM Global Investors's largest Q3 2022 buy was BELLUS Health Inc.: 583,593 shares worth $6.19M.
  • EAM Global Investors added most to e.l.f. Beauty in Q3 2022, an estimated $2.46M increase.
  • EAM Global Investors's biggest Q3 2022 reduction was BancFirst, cutting an estimated $2.31M.
  • EAM Global Investors fully exited FLEX LNG in Q3 2022, selling an estimated $7.59M.
  • EAM Global Investors's ten largest holdings make up 14% of its $376M portfolio in Q3 2022.
  • EAM Global Investors opened 96 new positions and closed 103 in Q3 2022.
  • EAM Global Investors's portfolio value fell 7.7% quarter-over-quarter to $376M.

Based on EAM Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.